HealthTech Roundup! #009

Welcome back to HealthTech Roundup! The landscape has evolved faster than a New Year's Eve countdown since the last issue 🎇🎆! Buckle up for a ride through the latest in digital health, big tech, innovation and government:

First up, fresh news bites 🥪:

• Google and Quest Diagnostics have teamed up to explore how wearable technologies can improve metabolic health.

• Artificial Intelligence (AI) took centre stage at the World Economic Forum, with discussions on its potential to address complex healthcare challenges. Read it with: Patient-First Health with Generative AI: Reshaping the Care Experience whitepaper.

• LillyDirect launched earlier this month, offering Eli Lilly patients access to HCPs via telehealth, educational content, and an online pharmacy. This move aligns with recent digital health trends in the industry, including Sanofi’s partnership with DarioHealth and AstraZeneca’s spin-out, Evinova.

• Mixed-reality and AI-powered platform, HoloCare, is to be deployed at the NHS this year, with European hospitals to follow. The platform creates interactive 3D holograms of a patient’s organs, enabling surgeons to precisely plan and personalise surgeries.

Cool things innovators are doing 🚀:

• Rad AI has scored a partnership with Google to help radiologists save time and reduce employee burnout, while improving the quality of patient care.

• Doctor Anywhere plans to incorporate generative AI to build new care solutions for predictive healthcare needs assessment and streamlined appointment scheduling.

Finally, leaving you with a futurist tidbit 🤖:

• The creation of Brainoware, a biohybrid computer blending a brain organoid with AI, marks a new era in machine learning. This technology is especially promising in early detection of neurodegenerative diseases and tumours.

One last nugget for the Aussies: 10-year digital health pipeline 🌟

• Unveiled in December 2023, the Digital Health Blueprint 2023-2033 is poised to revolutionise personalised, person-centred care through joint data sharing and digital transformation. At its core, the vision is to empower consumers with enhanced choice, access, and control over their information and services. The Blueprint aims to establish a healthcare system that is not only more interconnected and efficient but also sustainable and responsive to emerging technologies. It supports HCPs by providing real-time virtual access to each other and patients, and the information they need for effective decision-making. Read it with: Unleashing the Potential of our Health Workforce, where technology has been identified as top 5 driver.

• From a pharma perspective, the Blueprint presents a significant opportunity. Pharma can harness this potential through strengthening strategic partnerships and continuing to deliver innovation in collaboration with healthcare ecosystems, as well as local, state, and federal governments.

Phew! That was quite the ride – we had a lot of ground to cover over the last two months!